Non-Medication Anxiety Support: Wearable Vagus Nerve Stimulator Announced

Sep 22, 2026

Nuropod is now available in North America, offering a wearable vagus nerve stimulation device designed to support the body's natural calming response without medication.

Sacramento, United States, September 22, 2026 /PressCable/ -- As per a recent company announcement, Nuropod is now available in North America, providing consumers with a wearable vagus nerve stimulation device designed to support relaxation and the body's natural calming response through non-invasive neuromodulation. Developed for everyday wellness, the device offers a research-backed option for people looking to support nervous system health as part of their daily routine.

More information is available at https://nuropod.com/

The announcement comes as more people look for non-pharmaceutical approaches that complement healthy lifestyle habits and support relaxation. Designed to support the body's natural calming response, and supported by research from the Journal of Physiology and other publications, non-invasive vagus nerve stimulation devices are increasingly being incorporated into daily wellness routines by people seeking to feel less mentally and physically overloaded over time.

Nuropod works by clipping a small wearable earpiece onto the tragus, the part of the outer ear just in front of the ear canal where the vagus nerve reaches the skin. Using Parasym's proprietary AVNT™ approach, the device delivers gentle electrical stimulation to support that natural system. "The goal is to work with the body's own calming mechanisms through comfortable, everyday use," a company spokesperson said.

Many people incorporate Nuropod into quiet moments that already fit naturally into their day, such as reading, unwinding after work, or during meditation, adds the representative. Most users wear the device for around 30 minutes once or twice a day while continuing with their usual activities, allowing nervous system wellness to become part of an established routine.

Nuropod is supported by more than 10 years of vagus nerve stimulation research connected to Parasym, including over 60 peer-reviewed scientific studies, more than 150 research collaborations, and over five million neuromodulation sessions. In clinical studies, anxious thoughts fell by an average of 35%. Research has also reported improvements in vagus nerve activity, heart rate variability, and relaxation-related nervous system markers. "Our focus has always been to make research-backed neuromodulation practical for everyday wellness," the Nuropod spokesperson added.

Those interested can find additional information by visiting https://nuropod.com/blogs/articles/best-vagus-nerve-stimulation-device-for-anxiety

Disclaimer: Research referenced in this article was conducted using Parasym's neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as guaranteed individual outcomes. Nuropod is classified by the FDA as a non-designated risk device and is not intended to diagnose, treat, cure, or prevent any disease.

Contact Info:
Name: Victor Kho
Email: Send Email
Organization: Nuropod
Address: 2108 N Street, Sacramento, California 95816, United States
Website: https://nuropod.com/

Source: PressCable

Release ID: 89204015

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.

More News

'We screwed up': Doordash admits underpaying New York workers
Sep 22, 2026
'We screwed up': Doordash admits underpaying New York workers

The food delivery giant will pay a $131.5m settlement following a city probe into wage violations.

Global Oil Price Drops Below $100 a Barrel
Sep 22, 2026
Global Oil Price Drops Below $100 a Barrel

Investors anticipated that a damaged Saudi Arabian pipeline may be close to reopening, allowing more oil from the region to reach world markets.

Trump Is Back on TV, Briefly, as Many Networks Carry His U.N. Speech Live
Sep 22, 2026
Trump Is Back on TV, Briefly, as Many Networks Carry His U.N. Speech Live

A suspension of pool coverage remains in effect. But the in-house United Nations broadcaster provided a feed of the president’s remarks.

Sir Jim Ratcliffe suspends production at key UK plants blaming high gas prices
Sep 22, 2026
Sir Jim Ratcliffe suspends production at key UK plants blaming high gas prices

Ineos said natural gas in the UK is twelve times more expensive than in the US.

How Unions Are Confronting A.I. Threats in the Workplace
Sep 22, 2026
How Unions Are Confronting A.I. Threats in the Workplace

The machinists union shows how workers are negotiating for a say in the ways artificial intelligence is used in their workplaces.

What Is the White House Press Pool, and Why Did It Suspend TV Coverage of Trump?
Sep 22, 2026
What Is the White House Press Pool, and Why Did It Suspend TV Coverage of Trump?

By barring CNN, the White House has thrown a staple of TV news coverage into disarray.

CNN’s Future Will Include an Editorial Oversight Board
Sep 22, 2026
CNN’s Future Will Include an Editorial Oversight Board

The looming ownership of the network by David Ellison has caused anxiety in its newsroom for months.

What’s Next for Paramount
Sep 22, 2026
What’s Next for Paramount

Hollywood watchers believe the studio prevailed over states seeking to block its deal for Warner Bros. Discovery. It’s now free to reshape the media industry.

China’s Continued Control of Rare Earths Looms Over Trump-Xi Meeting
Sep 22, 2026
China’s Continued Control of Rare Earths Looms Over Trump-Xi Meeting

Manufacturers are struggling with constrained supplies as U.S. and Chinese officials negotiate over export restrictions with consequences for global industry.

Paramount settles lawsuit with US states, clearing way for $110bn merger with Warner Bros
Sep 22, 2026
Paramount settles lawsuit with US states, clearing way for $110bn merger with Warner Bros

The deal includes an agreement to produce 30 films a year, or Paramount will be forced to sell off parts of its company.

Are vet bills about to get cheaper?
Sep 22, 2026
Are vet bills about to get cheaper?

Written prescription fees from vets will be capped at £21 as part of a raft of changes that practices will be legally required to bring in over the coming months.

Spain battles climate change on several fronts
Sep 22, 2026
Spain battles climate change on several fronts

A summer of wildfires and heatwaves underlines the threats to the country's economy.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter